Silicon Laboratories Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $855.9M+46.5% YoYTTM through 4 Jul 2026
Net Income -$39.1MTTM through 4 Jul 2026
Free Cash Flow -$5.4MTTM through 4 Jul 2026
Margins
| Current | |
|---|---|
| Gross Margin | 58.2% |
| EBITDA Margin | -0.6% |
| Operating Margin | -9.0% |
| Net Margin | -4.6% |
Returns
-5.9%ROE
-5.1%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio4.69x
Net Debt-$443.6Mnet cash position
Cash & Equivalents$362.2M
Quality Metrics
Altman Z-Score30.19
Piotroski F-Score6 / 9
FCF Margin-0.6%
Rule of 407.9
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2026: $784.8M
Diluted EPS-$1.17TTMFY2026: $-1.98
Dividend
No dividend
Capital Allocation
R&D Spend$360.8M
Capex Intensity4.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Industrial & Commercial | $444.9M | +31.4% | View detailsGuidance suspended due to pending acquisition by Texas Instruments. |
| Home & Life | $339.9M | +38.2% | View detailsGuidance suspended due to pending acquisition by Texas Instruments. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.